London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
i really don't get why you feel the need to keep pushing this same article, fours times now, and today just before market open... hmmm, I already replied to you:-
There was something like 53 different cancer drugs licensed in 2020 and approaching similar number this year. There was something like 16 for breast Cancer. They all have different qualities in the fight to cure these awful diseases.
If AZ have one, they are working on that’s also great, the market is ginormous, we need as much support as possible.
In simplistic terms at the other end of the scale we have zillions of variations of Paracetamol being licensed and brought to the market every year.
I see it as a positive if AZ have one in trials then some of the other big pharma players may be more likely to license VAL201 to also have a product in trials they may be able to also take in this market.
look at the recent Covid vaccine market, there were about 10 players at the start of the race and we ended up with five worldwide was it?
Anyhow, lets see what Suzy has to say tomorrow
Morning all heres to a good week :) A1 if you dont like here why dont you go play with the Trafic its rush hour now you will have lots of fun....
Perhaps the poster just feels the need to de-ramp or something, most odd
Anyhow, presentation tomorrow so all to play for..
GLA shareholders old and new
The push now through the 40p level ....
At £17 m mcap can't go far wrong at this level
Here's to a good week
Brixton apologies just checked and noticed the drop in sept 20. Thank god I sold up before that, I bought in around 10p old money in2008 when it crashed.
Brixton when was RBS £1? I remember it dropped to around 10p in 2008 and rose to around over 40p they then did the 10-1 consolidation at around 25p making it around £2.50 then it dropped to around £1.70 slow climb to today’s price since. Hmmmm
Anyone else with PR and marketing experience that can add here might be better qualified to answer. My own thoughts are that PR now needs to be much higher on the company’s agenda than previously. They need to take it up a gear, their PR machine is NOT doing enough imo. The website is amazing, that was a brilliant start.
I did contact Suzy and suggest that after the presentation once the Q&As are uploaded and its syndicated around that she contacts someone like Paul Hill at VOX markets and have them interview her about the progress. It then introduces VAL to yet another investor audience.
Zac Mir at the Traders Café last week picked up on the stock in break out and he would no doubt link back to that sort of coverage for future updates. Again, we need more of this kind of interaction.
Likewise, the online share magazines and the mainstream media. There are numerous investor portals that could also cover this. The interview she did with Tom Froggatt got the brand name out, they just need to do more of it and more regular.
Shareholders don’t want to be left hanging just waiting for that one license deal RNS to land, they want regular updates and events to work towards, to talk about, that’s how I see it anyhow. New interest in what they are doing creates new shareholders.
If you google Valirx in google news, Zac Mir shows from the other week and little else, this tells us that the PR isn’t strong enough. The company needs to be talked about more to get noticed.
Also, we mustn’t lose sight of the fact that this is a female CEO in a business specialising in the development of treatments in cancer and women’s health to improve patient lives, this is big news in itself, it’s also a red-hot topic. Unless the company bangs the drug about how great they are no one else will. More must be done to get their name out there.
Finally, I’m not sure outsourcing PR is the right way to go, it might be worth them employing someone inhouse to help support. Anyhow, will add the question “what are their future plans for PR” to the portal for Q&A, maybe Suzy can expand on Tuesday.
Porky. I dont post much anywhere but your posts on here are excellent. I not your remarks about val being under the radar and trying to raise the company's profile. Just wondering what your thoughts are on their PR machine? Do u think they should b doing more because they do get paid for that role?
So we can't be Ultra Positive about our investment here, is that what you are trying to say?
Anyhow, your last contributions here to the Valirx Stock Board were as follows:-
19/9 - 3 line post thanking Grace for her post
17/9 - 2 line diss of another poster
15/9 - 2 line Off topic to LTH Baldy
8/9 - 3 line off topic about walking the dog
29/8 - you actually made an on topic post about Dr Kevin Cox
Prior to that you posted a comment on 25th July.
How is that helping create any interest here? How is that helping anyone start research and investigate further what Valirx is about? frankly your posts here are about as useful as teats on a Boar.
I guess one post of content in two month is better than nothing?
At least I'm trying to bring attention to the company, they are currently under the radar they need and deserve to be talked about. They need to attract new investor interest and they have a lot for investors to be excited about.
Anyone reading this thread can green bin me and totally ignore what i write if they don't want to read my comments. It's no wonder this stock has struggled to attract new interest this last 12 mths. Amazing
He is "ramping" as there is no substance to any of his posts - albeit repeating what we already know with an added dose of "ramptastic" (new word?)
I much prefer the detailed medical knowledge of Grace, Adam etc rather than the shenanigans of an AIM charlatan.
I don't consider Pork's posts as ramps because we have been very undervalued for over a year now. We were mainly stuck at 19-22p range for most of the year with no real help from the board. The price was also held up by long term investors buying more shares.
Until we reach a level which fairly reflects the assets that we have then I think we should continue to be positive and appreciate positive posts from Porky and others that are aimed more at new investors. We need interest to get us moving to a decent level.
Suzy and the board have done little to nothing so far to add value to the share price but I believe that will change soon with a deal or two and I am sure they have been working hard in the background. If anything I would say the lack of positivity and detail in the RNS for the 201 results was the main reason for the slump and led most to sell.
I made £250 on sirius minerals lol , but I only put £200 in , some peeps lost £30k
Pension monies plus , totally bent . However I did buy a good lump in Nat West "contract note " RBS for £1 now £2.17.60 similar Lloyds . Aim is corrupt.
How very rude, we are indeed awaiting to hear from Suzy on Tuesday
Two VERY different stocks, one big difference is that here the company care about their shareholders at Nova the outgoing CEO communicated and was positive until his LTIP plan qualified his £7m bonus and after that point when He no longer had a vested interest in the SP doing well he couldn’t care less. I have reduced my position over there following a further update I am not happy about. I have significant research and reduced as a result. Any shareholder is entitled to change their portfolio positions if they no longer marry with their own original risk assessments - the position at Nova changed materially
THis is a totally different Aim stock with different challenges
I just looked at the Nova board " not invested though " .
Aim is bent always has been always will be . It's gambling . The posts are bent and fantasy , research on aim is bent also , but I love to have a go at aim but moderately.
Porks, I see you're getting plenty of stick on the NOVA board - £54 indeed!!
Don't reply as I've green binned you so I don't have to wade through your rampy diatribes.
This used to be a decent board (with a couple of exceptions), so I suggest you shut up and wait for Suzy.
My original £400 was just toe in water and ended £1.66 correct that is aim porky .
But I did top up . My aim shares are financed out of divi's, good luck all.
I really appreciate there are some disgruntled shareholders that capitulated their positions here. Gawd knows i would be non to happy if i had brought in at £ 11 share price to find the share is now 28 pence. I totally get that.
But i don't see any point in posting here to disrupt, start idiotic threads or de-ramp, the share is not for everyone, its on AIM and it comes with risk, there are no guarantees. That's how it is.
I see this on loads of stock boards, with posters joining stock threads just to disrupt, ADVFN is the worst as many threads are just full of juvenile comments, it's so pointless and absolutely ridiculous. I don't want to sound uncaring but i'm really not that interested in what happened or who did or didn't invest here historically or if other biotech's are working on other drugs to combat diseases or if someone lost a fortune or someone doesn't like the business or someone has plain just given up on them. I'm only interested in this business as an investment proposition from here. It's share price has crashed down at this level for a reason. If everything was proven the Share price would be materially higher. The question now is, can i ultimately make a profit buying in at this price? and its a resounding YES from me.
Personally, i think its a cracking opportunity to invest in a Biotech with a number of projects on the go at an oversold share price level that now represents significant upside potential.
At 28p there is major upside to be had here, when we break the first pound that's circa a 4X ROI, yes i fully appreciate those in at £11 will still be 90% down on paper but the recovery has to start somewhere.
New investors coming in now are Investing at a time where historic mistakes have been learned and overcome, a new management team and direction are in place and a number of projects have advanced on towards licensing stages. The investment risk profile today at 28p is far, far better than it ever was at £11 as i see it.
So with a totally new Management team in situ, a totally different business plan and vision to where they were historically and the new team led by Suzy Dilly that really care about their shareholders and are doing things differently, everything is fully in play as i see it.
Meet the company presentation is on Tuesday and I suggest those in any doubt join and hear directly from the horses mouth, what the forward vision is, where they are on current projects and go from there:-
I have EVERY confidence in the management team here and i back this company fully.
Good Luck All